Catalyst Capital Advisors’s Bausch Health BHC Stock Holding History

Catalyst Capital Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-62,825	Closed	-$4.65M	–	505
2015 Q4	$6.39M	Sell	62,825 -30,095	-32%	-$3.38M	0.93%	34
2015 Q3	$16.6M	Sell	92,920 -2,370	-2%	-$553K	2.22%	2
2015 Q2	$21.2M	Buy	95,290 +94,965	+29,220%	+$21.1M	2.47%	1
2015 Q1	$65K	Sell	325 -122,443	-100%	-$21.7M	0.01%	318
2014 Q4	$17.6M	Buy	122,768 +122,520	+49,403%	+$16.5M	2.06%	5
2014 Q3	$33K	Sell	248 -39,670	-99%	-$4.73M	﹤0.01%	325
2014 Q2	$5.03M	Buy	39,918 +10,000	+33%	+$1.28M	0.82%	36
2014 Q1	$3.94M	Buy	29,918 +2,023	+7%	+$277K	0.89%	20
2013 Q4	$3.27M	Buy	27,895 +15,159	+119%	+$1.66M	1.06%	12
2013 Q3	$1.33M	Buy	+12,736	New	+$1.24M	0.73%	30

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Catalyst Capital Advisors's BHC Position: Q1 2016 in Review

Catalyst Capital Advisors sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 62,825 shares — an estimated $4.65M sold.

Catalyst Capital Advisors first reported a position in BHC in Q3 2013 and held it in 10 quarters. The position peaked at $21.2M in Q2 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

Catalyst Capital Advisors reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
Catalyst Capital Advisors sold 62,825 Bausch Health shares in Q1 2016, an estimated $4.65M.
Catalyst Capital Advisors first reported a position in Bausch Health in Q3 2013 and held it in 10 quarters.
Catalyst Capital Advisors's Bausch Health position peaked at $21.2M in Q2 2015.
389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Catalyst Capital Advisors's 13F filing for Q1 2016, filed 11 May 2016.